Use of Chemotherapy and Androgen Signaling-targeted Inhibitors in Patients with Metastatic Prostate Cancer

被引：4
|
作者：
de Wit, Ronald [1 ]
Tombal, Bertrand [2 ]
Freedland, Stephen [3 ,4 ]
机构：
[1] Erasmus Univ, Med Ctr, Med Oncol, Rotterdam, Netherlands
[2] Catholic Univ Louvain, Inst Rech Clin, Louvain, Belgium
[3] Cedars Sinai Med Ctr, Div Urol, Los Angeles, CA 90048 USA
[4] Durham VA Med Ctr, Sect Urol, Durham, NC USA
来源：
EUROPEAN UROLOGY | 2021年 / 79卷 / 02期
关键词：
INCREASED SURVIVAL; ENZALUTAMIDE; ABIRATERONE;
D O I：
10.1016/j.eururo.2020.10.016
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：170 / 172
页数：3
相关论文
共 50 条
  • [21] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332
  • [22] Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
    Fiorica, Francesco
    Buttigliero, Consuelo
    Grigolato, Daniela
    Muraro, Marco
    Turco, Fabio
    Munoz, Fernando
    Tucci, Marcello
    CURRENT ONCOLOGY, 2022, 29 (12) : 9511 - 9524
  • [23] Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)
    Jensen, Jeffrey L.
    Bobek, Olivia
    Chan, Irenaeus C. C.
    Miller, Brian C.
    Hillman, David W.
    Heller, Glenn
    Druley, Todd
    Armstrong, Andrew J.
    Morris, Michael J.
    Milowsky, Matthew I.
    Beltran, Himisha
    Bolton, Kelly L.
    Coombs, Catherine C.
    CLINICAL CANCER RESEARCH, 2024, 30 (21) : 4910 - 4919
  • [24] Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer Setting
    Sayegh, Nicolas
    Tripathi, Nishita
    Nussenzveig, Roberto H.
    Thomas, Vinay Mathew
    Tandar, Clara
    Goel, Divyam
    Nordblad, Blake
    Sahu, Kamal Kant
    Li, Haoran
    Maughan, Benjamin L.
    Agarwal, Neeraj
    Swami, Umang
    EUROPEAN UROLOGY FOCUS, 2023, 9 (01): : 106 - 109
  • [25] Advances in Androgen Receptor Targeted Therapy for Prostate Cancer
    Ahmed, Alia
    Ali, Shadan
    Sarkar, Fazlul H.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (03) : 271 - 276
  • [26] Therapeutic targeted approaches on androgen receptors in prostate cancer
    Ferrand, F. -R.
    Pavic, M.
    REVUE DE MEDECINE INTERNE, 2014, 35 (10): : 670 - 675
  • [27] Global efficacy and clinical application of androgen receptor inhibitors in metastatic prostate cancer
    Vaishampayan, Ulka
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (06)
  • [28] The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer
    van Soest, R. J.
    Nieuweboer, A. J. M.
    de Morree, E. S.
    Chitu, D.
    Bergman, A. M.
    Goey, S. H.
    Bos, M. M.
    van der Meer, N.
    Hamberg, P.
    de Wit, R.
    Mathijssen, R. H. J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (17) : 2562 - 2569
  • [29] Earlier use of androgen receptor-axis-targeted drugs may improve overall survival in patients with non-metastatic castration-resistant prostate cancer
    Mori, Keiichiro
    Kimura, Takahiro
    Ito, Kagenori
    Onuma, Hajime
    Tanaka, Masatoshi
    Matsuura, Taishi
    Kurokawa, Gaku
    Iwatani, Kosuke
    Inaba, Yuzo
    Sakanaka, Keigo
    Sasaki, Hiroshi
    Miki, Jun
    Shimomura, Tatsuya
    Miki, Kenta
    Egawa, Shin
    PROSTATE, 2018, 78 (10) : 766 - 772
  • [30] Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer
    Koshiro, Nishimoto
    Nakajima, Kenichi
    Oyama, Masafumi
    Kaneko, Go
    Takahashi, Satoru
    Matsuyama, Hideyasu
    Shiina, Hiroaki
    Ichikawa, Tomohiko
    Horikoshi, Hiroyuki
    Hashine, Katsuyoshi
    Sugiyama, Yutaka
    Miyao, Takeshi
    Kamiyama, Manabu
    Harada, Kenichi
    Ito, Akito
    Mizokami, Atsushi
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (12) : 1477 - 1487
12345